Trials with Maya Z (Maya Zlatanova)
Explorez tous les épisodes de Trials with Maya Z
| Date | Titre | Durée | |
|---|---|---|---|
| 08 May 2024 | The Future of AI-Powered Trials with Stefan Schröder | 00:35:01 | |
How can we harness the power of AI to create more patient-centric clinical trials? Can technology and empathy coexist in healthcare? In this episode, Maya meets Stefan to explore the integration of artificial intelligence in clinical trials. Stefan and his team at Enroll With assist clients in using AI to improve various aspects of clinical trials, from site selection to creating content and virtual patient simulations that can eliminate the need for placebo patients. Although it may seem contradictory, they believe that technology can make healthcare more human-centered, ultimately helping people recover faster. Maya and Stefan reveal a vision for the future where AI not only optimizes trials but also strengthens the connection between science and humanity. (03:58) The broken state of clinical trials (06:47) AI’s role in bringing a big change in trials (13:20) Exploring AI solutions (27:34) What’s the AI integration in Pharma (32:15) Why empathy is what we need in clinical trials now Follow our LinkedIn page for more insights from the world of clinical trials. Maya Zlatanova, CEO of TrialHub Stefan Schröder, Founder of Enroll With
| |||
| 08 Feb 2024 | How to Improve Integrity in Clinical Research with Leeza Osipenko | 00:33:48 | |
In this episode, Maya meets Dr. Leeza Osipenko. She is the founder and the CEO of a non-profit organization Consilium Scientific. It is dedicated to improving the integrity of clinical research. Maya and Leeza discuss the following topics: (2:18) The role of NICE in developing clinical standards (6:23) Why did Leeza start Consilium Scientific (9:35) How to avoid suboptimal clinical trials (19:02) What are the mechanisms that improve clinical research integrity (25:30) The ultimate goal of Consilium Scientific (32:47) What is the biggest challenge in clinical trials at the moment Tune in today for a thrilling journey into the world of clinical research – expand your knowledge! Maya Zlatanova, CEO of Trialhub Leeza Osipenko, CEO of Consilium Scientific See More: | |||
| 08 Oct 2024 | Building the Batman Belt: Leveraging Data and Standard of Care in Trials with Travis Caudill | 00:41:39 | |
Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/
| |||
| 29 Oct 2024 | Real-world data: The Good, the Bad and the Ugly with Jan Poleszczuk from CliniNote | 00:22:16 | |
Meet Jan Poleszczuk, a mathematician turned healthcare innovator and a CTO of CliniNote. In this episode Maya and Jan talk about:
Learn more about CliniNote: https://clininote.com/
| |||
| 22 Mar 2023 | Challenges and Considerations in Pediatric Clinical Trials with Jacqui Whiteway | 00:41:57 | |
In this episode, Maya and Jacqui provide invaluable insights into the unique considerations that go into designing and executing pediatric clinical trials. From navigating ethical concerns to ensuring that children are properly represented in study populations, they cover all the key factors that can make or break a trial. But it's not just about the technical details – Maya and Jacqui also bring a human touch to the conversation. They discuss the impact that clinical trials can have on children and their families and share personal anecdotes that highlight the importance of putting the needs of patients first. Tune in today and start expanding your knowledge! Here are the key topics that they discuss: (3:34) Challenges in planning pediatric clinical trials (8:30) Are decentralized trials improving pediatric research? (13:30) What should we change in pediatric trials to make them more successful? (18:49) Lack of resources and awareness in planning pediatric clinical trials (22:11) Differences between trials for adults, adolescents, and children (28:11) Problems in communication in the healthcare industry (29:06) Helping with anxiety and trauma in clinical trial patients Tune in to learn more! Maya Zlatanova, CEO of Trialhub Jacqui Whiteway, Senior Director & Pediatric Strategy Liaison at ICON plc | |||
| 02 Apr 2024 | Why Diversity in Trials Is Doomed Until We Fix Reimbursement with Sam Whitaker | 00:41:13 | |
In this episode of 'Trials with Maya Z', host Maya Z interviews Sam Whitaker from Mural Health, discussing the pressing issue of patient reimbursement in clinical trials. Sam Whitaker is a Founder and CEO of Mural Health, a tech company on a mission to make it easy to participate in clinical research. Mural Health was founded in 2022 as Sam’s effort to evolve the product he invented, the ClinCard, when he founded Greenphire in 2008. Maya and Sam explore how one-third of Americans are excluded from participating in clinical trials due to financial constraints and eligibility for welfare programs. The dialogue highlights the need for the clinical research industry to address financial barriers. Here are the topics Maya and Sam deep dive into: (01:03) Introducing Sam Whitaker: The Man Behind a Great Mission (03:01) The Reimbursement Dilemma: How It Affects Patient Diversity in Clinical Trials (20:30) Exploring Solutions: Legislative Efforts and Centralized Reimbursement Models (31:15) Empowering Change: How You Can Support and The Ideal World for Clinical Trials
Sign the letter to Congress and support Sam’s mission. Tune in today for a thrilling journey into the world of clinical trials – expand your knowledge! Maya Zlatanova, CEO of Trialhub Sam Whitaker, CEO of Mural Health See More: | |||
| 08 Mar 2023 | Clinical Trials During War Times in Ukraine with Yurii Lebid | 00:22:03 | |
Maya Zlatanova speaks with the CEO of Pharmaxi LLC, Yurii Lebid. Pharmaxi is a clinical research organization based in Ukraine and operating in the Eastern European market. It was one of the first clinical organizations to restore clinical trials after the war began. Maya and Yurii examine the clinical trial process during the war in Ukraine and the challenges in patient recruitment. They dive deeper into success factors in clinical trials, patient and data safety, etc. Here are the key topics that they discussed: (2:34) How were clinical trials run prior to the war in Ukraine (4:09) Factors that make Ukraine an appealing clinical trial destination (8:45) How the clinical trial landscape changed after the war (11:16) What factors are relevant to Ukraine’s success today? (14:45) What are Ukraine’s current challenges in running successful clinical trials? (17:48) What extra measures are taken to ensure patient and data safety? (19:34) What was the approval procedure for the first clinical trial after the war started? Tune in to learn more! Maya Zlatanova, CEO of Trialhub Yurii Lebid, CEO of Pharmaxi LLC | |||
| 09 May 2023 | What Makes or Breaks a Clinical Trial Event with Alex O’Leary | 00:21:58 | |
In this episode, Maya’s guest is Alexander O’Leary, Director of the PBC Group which hosts the Clinical Outsourcing Group (COG) event series with events in the UK, Europe, and the USA. He has close to 14 years of experience in organizing and running clinical research events. Maya and Alex discuss clinical research events both from the perspective of organizers and attendees. They deep dive into the biggest challenges and mistakes when planning and executing industry events Here are the key topics that they discuss: (2:17) How do you find out what the most important topics for events are? (3:57) Do events only cover topics on a superficial level? (5:51) What makes or breaks a clinical trial (event)? (8:54) Is it possible to create a synergy among the three stakeholders at events? (13:09) How do you bridge the communication gap between patients and the industry? (14:15) Why do people choose the attend a certain clinical research event? (17:27) How do I select the right clinical trial event for my needs? (19:34) Can events accelerate change in the clinical research industry? Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Alexander O’Leary, Director of PBC Group See More: | |||
| 01 Oct 2024 | How To Prevent Clinical Trial Nightmares With Ilknur Lechthaler | 00:22:34 | |
Ilknur Lechthaler is an expert in clinical operations, research, and startup investments. Ilknur discusses how the industry's awareness of the significance of country-specific standard of care has evolved over the past decade. Together with Maya they dive into the practical aspects of country selection and the factors that influence decision-making, such as regulatory requirements, timelines, and budget constraints. Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/ | |||
| 28 Nov 2023 | Leveraging Social Media for Patient Recruitment with Steve Wimmer | 00:34:52 | |
In this episode, Maya meets Steve. Steve is the VP of partnerships for 1nHealth. He brings a wide-ranging scope of experience to his role, having worked previously in digital marketing, e-commerce, and education. He is primarily responsible for assessing digital recruitment feasibility and developing external partnerships. Maya and Steve discuss the following topics: (2:00) The common things between patient recruitment and e-commerce (4:48) The 3 e-commerce tactics that can be applied to patient recruitment (11:57) Are iterations of patient recruitment ads expensive (13:53) The #1 platform for patient recruitment (19:59) Real-life stories from patient recruitment campaigns (27:48) What makes or breaks clinical trials Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Steve Wimmer, VP of Partnerships for 1nHealth See More: | |||
| 24 Sep 2024 | Mapping the Patient Journey: Roadmap to Successful Trial Design with Todd Georgieff | 00:42:21 | |
Meet Todd Georgieff - a veteran in drug development and clinical operations with expertise in optimizing global trials. In this episode, Todd and Maya explore the critical aspects of protocol optimization and patient burden quantification. How does understanding local standard of care impact trial success? What are the ethical implications of providing treatments in different healthcare systems? Todd shares insights on these questions and more.
| |||
| 22 Oct 2024 | Understanding the Patient Journey is Our Duty as Researchers: Esther Howard's Insights from Two Decades in Clinical Research | 00:33:45 | |
Meet Esther Howard, Mental Health Advocate, Researcher and CEO of Bezyl. In this conversation, Esther shares her unique perspective on the importance of understanding patient journey, not just as a scientific necessity, but as a fundamental human duty for researchers. Esther explores the three critical prongs of patient journey: standard of care, the specifics of the patient's disease, and the often-overlooked aspects of their daily lives. She emphasizes the need for researchers to look beyond the protocol and embrace a more holistic view of patients' experiences, arguing that by embracing our human duty to understand and empathize with patients' experiences, we can not only advance scientific knowledge but also create a more compassionate and patient-centric approach to clinical research.
| |||
| 02 Aug 2023 | How Empathy Impacts the Pediatric Patient Experience with Aaron Horowitz | 00:22:00 | |
In this episode, Maya and Aaron Horowitz, CEO & Founder of Empath Labs, dive deeper into the role of empathy in clinical trials. They discuss the following topics: (2:43) Why did Aaron create Emapth Labs? (4:46) How does the teddy bear from Empath Labs work? (8:21) How does Aaron get inspired to create these products? (11:09) How can you engage pediatric patients and understand their experience? (14:46) How do companies feel toward the product? (16:43) At what stage do CROs need the Empath Labs products? (20:11) What is coming up next at Empath Labs? Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Aaron Horowitz, Founder & CEO at Empath Labs See More: | |||
| 04 Oct 2023 | Clinical Trials From a Patient’s Perspective with Carole Scrafton | 00:30:05 | |
In this episode, Maya sits with Carole Scrafton, Director and Co-Founder of a Patient Advocacy Organisation. They deep dive into the following topics: (4:00) How has access to clinical trials altered? (8:36) Do companies approach patients for clinical trials? (11:47) How to assess proposals from small companies? (16:13) Who should be more proactive: doctors or patients? (19:55) Carole’s first experience with a clinical trial (24:35) How to accelerate change in clinical trials? Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Carole Scrafton, Director & Co-Founder of Flutters and Strutters See More: | |||
| 26 Aug 2024 | Fail-Proofing Clinical Trials: Lessons in Smart Planning with Angie Schwab | 00:33:13 | |
Meet Angie Schwab - founder of EZ Research Solutions and a passionate expert in clinical research with a focus on improving trial startup processes. In this episode, Angie and Maya dive deep into the challenges and solutions in clinical trial design and execution. Angie shares her insights on the critical importance of thorough planning, understanding local standards of care, and involving all stakeholders - including patients - in study design. They explore how poor initial planning can set trials up for failure and discuss innovative solutions, including the role of automation and AI in streamlining processes and reducing errors. Angie's vision for the future of clinical trials, emphasizing digitalization, standardization, and intelligent study design from the ground up, offers a compelling look at the evolving landscape of clinical research. Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/
| |||
| 07 Mar 2024 | How to Market Clinical Trials to the Right Participants with Colin Sholes | 00:26:59 | |
In this episode, Maya meets Colin Sholes. Colin is the founder of Cure Clinical Inc., a US-based software company building a comprehensive database for clinical research performance analysis. Maya and discuss the following topics: (4:29) Why is a direct-to-consumer business similar to patient recruitment (8:06) How to balance the pitch to patients with the site demands (11:23) How to achieve consistency in patient recruitment ads (14:40) Are sponsors and CROs reacting to clinical sites direct feedback (16:58) How does Cure Clinical make trials more scalable (20:50) Do sites need better statistics or better tools (24:00) The #1 solution to make trials more patient-friendly Tune in today for a thrilling journey into the world of clinical trials – expand your knowledge! Maya Zlatanova, CEO of Trialhub Colin Sholes, Founder of Cure Clinical See More: | |||
| 20 Aug 2024 | Rethinking The Role of Standard of Care in Clinical Trials With Dan Sfera | 00:28:14 | |
Dan Sfera really needs no introduction - founder of the Clinical Trials Guru he has been publishing content in the clinical research space since 2010. In this episode, Dan and Maya talk about the challenges of patient recruitment and retention, explore the importance of considering clinical trials as a care option, and the implications of not prioritizing the patient perspective in trial design.
Follow Dan Sfera: https://www.linkedin.com/in/dansfera
| |||
| 21 Feb 2024 | Tackling Immigrant Bias in Clinical Trials with David Rosenbaum | 00:26:00 | |
In this episode, Maya meets David Rosenbaum to talk about immigrants in clinical trials. David helps scatter the immigrant bias with clinical trials in Turkey and other Balkan countries. However, it’s an ongoing administrative effort. David is the Founder of Rosenbaum Group. It is a CRO operating since 2019 in the south-eastern Balkans and Turkey. The organization focuses on clinical trials in CNS, infectious diseases, and gastroenterology. It also supports BIOTECH research and medical devices with a patient-centric approach. Maya and David discuss the following topics: (2:30) Immigrant story from a clinical trial in Turkey (7:12) What makes immigrants vulnerable patients (9:50) The situation with immigrants and trials in the Balkans (12:48) Ways to improve communication with authorities (16:06) Tech portals vs direct communication with regulatory bodies (19:40) What can ethics committees improve further (23:02) The #1 thing to make trial patient-friendly Tune in today for a thrilling journey into clinical trials – expand your knowledge! Maya Zlatanova, CEO of Trialhub David Rosenbaum, Clinical Trial Manager @ Rosenbaum Group Ltd. See More: | |||
| 03 Jan 2024 | How to Make Clinical Trials More Transparent with Till Bruckner | 00:31:14 | |
In this episode, Maya meets Till, the founder of TranspariMED. Till is a political scientist by background, now focused on raising awareness about clinical trial transparency. Maya and Till discuss the following topics: (1:19) How to achieve transparency in clinical trials (3:37) Should all trials be fully transparent (5:26) The current state of clinical trial transparency (8:32) Who should enforce reporting clinical trial results (14:58) Who benefits from opacity in clinical trial results (20:35) How to foster better transparency in trials (29:54) What makes or breaks clinical trials Tune in today for a thrilling journey into the world of clinical trials – expand your knowledge! Maya Zlatanova, CEO of Trialhub Till Bruckner, Founder of TranspariMED See More: | |||
| 31 Jan 2025 | How to get from Sick Care to Health Care and Rethinking Pharma’s Role with Paul Simms | 00:36:13 | |
Paul Simms is the CEO of Impatient Health and a trailblazing voice in the life sciences industry. Paul is on a mission to push the boundaries of pharma. He works with innovators and early adopters to inject “mutation pressure” into the status quo, ensuring bold ideas and creative solutions make their way into the market. Drawing on his experience as a speaker, event organizer, and consultant, Paul discusses how pharma can evolve to truly align with patients’ needs. Together, with Maya they explore the intersection of innovation, behavioral science, and systemic transformation in healthcare. What You’ll Learn: | |||
| 19 Apr 2023 | Navigating Clinical Trials as a Small Biotech with Toni Perez | 00:26:38 | |
In this episode, Maya and Toni Perez discuss the challenges that small biotech companies face on a daily basis. Toni Perez has more than 36 years of experience in the clinical research industry. He has worked with both big and small pharmaceutical companies. Since 2007 he has been working as a consultant to smaller biotech companies with a headcount of 2 to 10. Maya and Toni dive deep into topics of leadership, trust, and teamwork when it comes to doing clinical research. Having the right expertise in your team is crucial for the successful completion of clinical trials. Here are the key topics that they discuss: (3:36) What are the top challenges that small biotech companies face? (5:03) What resources do you need when planning clinical trials as a small biotech? (7:49) How do you plan a clinical trial without much experience in the industry? (10:28) What type of professionals do you need in your team? (12:18) Pros and cons of hiring part-time vs full-time professionals (15:24) When should you work with a big CRO vs a small CRO? (20:40) What is Toni’s advice to CEOs without a clinical research background? Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Toni Perez, Founder of Toni Perez Pharma Consulting See More: | |||
| 15 Aug 2024 | How the Patient Voice Can Help Shape The Perfect Trial Design with Robert Joyce | 00:30:24 | |
Meet Robert Joyce - a patient advocate living with multiple chronic illnesses who has turned his experiences into a powerful voice for change in healthcare. In this episode, Robert and Maya explore the complex journey of living with secondary progressive multiple sclerosis, asthma, sarcoidosis, and chronic pain. They discuss the critical importance of including patient voices in clinical trial design, the impact of local standard of care on treatment decisions, and the need for improved communication and transparency in healthcare. Robert's insights shed light on the real-world implications of reimbursement rules, access to treatment, and the diversity of patient experiences in clinical trials.
Facebook: https://www.facebook.com/A30MinuteLife Twitter: https://twitter.com/A30MinuteLife Blog: https://www.A30MinuteLife.com Instagram: https://www.instagram.com/A30MinuteLife/ YouTube: https://www.youtube.com/channel/UC4QT-lK_dIzrHLdqGqatZ_g | |||
| 10 Sep 2024 | Viagra's Hard Lessons: Why Understanding the Patient Journey is Non-Negotiable with Annabel de Maria Bosch | 00:33:48 | |
Meet Annabel de Maria Bosch - the Chief Patient Officer at Alira Health with nearly three decades of experience in patient engagement across the pharmaceutical industry. In this insightful conversation, Annabel shares her unique perspective on the critical importance of understanding the patient journey and its impact on clinical trial success.
1)Stergiopoulos et al., Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development (2020); 2)Levitan et al., Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI’s Patient Groups and Clinical Trials Project (2018); 3)Getz, Establishing Return-on-Investment Expectations for Patient-Centric Initiatives (2015) | |||
| 15 Oct 2024 | Connecting the Dots in The Patient Journey - The Importance Of Patient Trust with Heidi Floyd | 00:20:40 | |
| |||
| 06 Jun 2023 | The Pros and Cons of CTIS with Martin Krauss | 00:29:43 | |
In this episode, Maya is discussing the pros and cons of the Clinical Trials Information System (CTIS) with the Managing Director of FGK Clinical Research GmbH, Martin Krauss. By background, he is a trained statistician with more than 25 years of experience in the clinical research industry. They dive deep into the following topics: (1:01) Who is Martin Krauss? (3:34) Has the CTIS improved transparency and centralization in clinical trials? (5:40) What are the strengths of the CTIS? (7:19) What are the weaknesses of the CTIS? (11:12) How does the CTIS help you as a CRO? (14:17) What is the impact of the CTIS on the sponsors? (15:38) Do you receive technical support from the CTIS? (19:19) The UK is outside the CTIS. Is that a plus or a minus for them? (21:18) Development of clinical trials in Europe vs USA (24:30) Martin’s recommendations for working with the CTIS Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Martin Krauss, Managing Director of FGK Clinical Research GmbH See More: | |||
| 03 Sep 2024 | The true cost of patient acquisition and the ever-rising site burden with Ted Trafford | 00:28:28 | |
Meet Ted Trafford - a seasoned clinical research expert with nearly three decades of experience and a passion for driving innovation in the industry. As the Director of Business Development at Probity Medical Research, Ted brings unique insights into the challenges faced by sites, sponsors, and patients in the clinical trial landscape.
Check out Ted's post mentioned in the episode: https://www.linkedin.com/posts/tedtrafford_clinical-trial-marathon-activity-7221841156958011392-tb1e | |||
| 20 Jun 2023 | Innovation in Clinical Research with Michelle Shogren | 00:28:31 | |
In this episode Maya and Michelle Shogren, CEO of Innovate in What You Do? LLC, are discussing the importance of innovation in clinical research. Michelle has been on both sides of clinical trials - as a patient and as part of the operations teams. She has almost 20 years of experience in different roles - caregiver, research coordinator, site and marketing director, CRA, and multiple roles in Pharma. Michelle is now running her own company with the same goal of helping people navigate and improve clinical trials. They dive deep into the following topics: (2:51) Top 3 Difficulties in Clinical Trials (5:23) How do you find innovative and sustainable solutions? (7:11) How do you integrate new solutions? (10:01) Incubation period when implementing a new change (14:09) How do you innovate while running a trial? (16:14) Common mistakes when integrating new solutions (18:10) How do you approach innovation in a small company? (22:19) How do you pitch your solutions in the best way? Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Michelle Shogren, CEO of Innovate in What You Do! LLC See More: Innovate in What You Do? LLC | |||
| 20 Mar 2024 | A Clinical Trials Odyssey with Ross Jackson | 00:35:40 | |
In this episode, Maya meets the author of two well-received books. Ross Jackson consults with and advises organizations within the clinical trials industry. He helps them improve patient recruitment and retention. Maya and Ross discuss the following topics: (0:51) What led Ross to write the books on patient recruitment (6:39) Patient recruitment in 1999 vs now (10:06) Doing country localization right (15:26) How to craft a solid patient recruitment strategy (14:58) Why DCT is the new norm now (24:11) Why aren’t satellite sites popular enough (28:02) Do we do clinical assessments right Tune in today for an odyssey into the world of clinical trials – expand your knowledge! Maya Zlatanova, CEO of Trialhub Ross Jackson, The Man Who Wrote the Book(s) on Patient Recruitment See More: | |||
| 24 Jan 2024 | The New Generation of Leadership with Andreas Beust | 00:31:08 | |
In this episode, Maya meets Andreas, who is a part of the new generation of CRO leaders. He has new ideas and concepts of how to bring better clinical research services to the market and make trials more accessible. Maya and Andreas discuss the following topics: (2:55) Why aren’t more students pursuing careers in clinical trials? (6:35) What does the Association of International CROs do? (10:49) How to balance global trial coverage with local support? (8:32) Should big companies manage local teams as mini-companies? (18:38) How to face clinical trial challenges as an international company? (24:43) What’s the future of clinical research organizations? Tune in today to catch the latest insights and emerging trends in the world of clinical trials. Maya Zlatanova, CEO of TrialHub Andreas Beust, CEO of GCP-Service International and President of AICROS See More: | |||
| 23 May 2023 | The Role of Mental Health Support in Clinical Trials with Esther Howard | 00:29:53 | |
In episode 7 Maya is talking to the founder and CEO of Bezyl Inc, Esther Howard. She has more than 20 years of experience in the health economics of developing countries and oncology clinical research operations. Her personal and professional experience inspired her to create her own company where she can focus on the mental health journey of every clinical trial patient. Maya and Esther deep dive into the following topics: (2:23) What is Bezyl Inc.? (4:16) What is the story of Bezyl Inc.? (10:36) Given your background, what would you change in clinical trials? (13:21) What practical advice would you give to address the patient’s and the site’s needs? (17:13) How can we make sure we consider the patient’s input in the best way possible? (19:46) What is the site’s role in patient engagement? (22:00) What is Esther’s project related to diversity in clinical trials? (27:48) The importance of focusing on the patient’s life and experience Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Esther Howard, SEO of Bezyl Inc. See More: | |||
| 14 Nov 2024 | The patient journey in US vs EU and how involving patients early on can help with Ella Balasa | 00:26:00 | |
Ella Balasa has experience on both sides of the research spectrum - as a patient with cystic fibrosis and as a scientist examining antibiotic-resistant bacteria. She is on a mission to amplify patient voices in drug development. In this episode Ella and Maya discuss:
Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/ | |||
| 05 Apr 2023 | How To Plan Better Clinical Trials with Dan Sfera | 00:24:35 | |
Looking to enhance your knowledge of planning clinical trials? Tune in to this insightful podcast episode with Maya and Dan as they discuss practical ways to plan better clinical trials. Discover the crucial roles that feasibility teams and CRAs play in clinical trials and how their involvement can significantly improve the success of the study. Additionally, learn about the importance of diversity in clinical trials and how we can make trials more accessible for a variety of populations. This can lead to better participant engagement and ultimately result in more accurate and reliable data. Don't miss out on this opportunity to learn practical ways to improve your clinical trial planning. Tune in now and take the first step toward planning more successful clinical trials! Here are the key topics that they discuss: (2:28) How are feasibility teams involved in the planning process (6:26) Do we need to work more closely with the coordinators? (8:03) Should sites turn to the CRAs to discuss any issues with the trial? (11:25) Are any extra endpoints discussed in the preliminary questionnaires? (13:38) Do these endpoints apply to diversity in clinical trials? (17:53) How can we shorten the distance between the sites and the decision-makers? (20:54) What would you change when planning clinical trials? Tune in to learn more! Maya Zlatanova, CEO of Trialhub Dan Sfera, Co-Founder and Site Director at Yuma Clinical Trials See More: | |||
| 06 Aug 2024 | What It’s Like to Build a Patient-Friendly Pharmacological Unit with Oren Cohen | 00:32:08 | |
In this episode, Maya meets Dr. Oren Cohen, who brings more than 30 years of healthcare, research, and clinical development experience to his role, including several senior medical and operational leadership positions at a biotechnology company and another global CRO. Oren is President at Fortrea Inc which has patient-friendly clinical research units in US and the UK. A hot topic is the unit in Leeds. It’s state of the art as Oren himself describes it. Created with patients in mind, this center is a true example in the industry. Would it resolve the patient recruitment challenge? Has Fortrea paved the way for the future of clinical trials? Maya and Oren unravel the secret sauce to success and much more in the latest episode. Watch it to learn about: (0:55) What’s Dr. Oren Cohen’s Professional Experience (2:37) Why Is Fortrea’s Unit in Leeds So Special (8:20) How Critical Is the Unit’s Structure to Trials Efficiency (14:10) Can We Replicate Fortrea’s Success in Leeds Elsewhere (16:57) Lessons Learned from Building a Patient-Friendly Pharmacological Unit (22:14) The #1 Thing to Make Trials More Patient-Friendly Maya Zlatanova, CEO of TrialHub Dr Oren Cohen, President, Clinical Pharmacology Services and Chief Medical Officer at Fortrea Inc.
| |||
| 31 Jul 2024 | Standard of Care or Clinical Trials: How Do Patients Choose Between Their Options? Conversation with Carole Scrafton | 00:26:56 | |
Meet Carole Scrafton, a passionate patient advocate and founder of Flutters and Stutters, a patient organization dedicated to improving the lives of those affected by chronic illnesses and rare diseases. In this episode, Carole and Maya explore how Standard of Care shapes the patient journey and experience throughout healthcare, going beyond just access to treatment. Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/
| |||
| 05 Jun 2024 | Decentralized Trials After the Hype with Moe Alsumidaie | 00:37:29 | |
In this episode, Maya meets Moe Alsumidaie, who is the Chief Editor of The Clinical Trial Vanguard. Moe holds two decades of experience in the clinical trials industry. The Clinical Trial Vanguard is an online platform that provides comprehensive information, analysis, and news related to clinical trials. It caters to a wide audience, including researchers, healthcare professionals, investors, and industry enthusiasts, aiming to keep them informed about the latest developments in clinical trials. Maya and Moe delve into the world of clinical trials, discussing decentralized clinical trials, the role of AI, regulatory trends, and patient-centric design. Moe shares insights on how to enhance the success and efficiency of clinical trials, emphasizing innovations like digital twins, digital biomarkers, and the need for trust and collaboration in the field. (02:42) Meet Moe Alsumidaie (04:29) Is the Momentum for DCT's Dying (09:02) Current Trends and Future Outlook of Decentralized Clinical Trials (14:00) The Role of AI in Clinical Trials (22:13) How Digital BiomarkersTransform Clinical Trials (25:35) Examples of Patient-Centric Approaches in Clinical Trials Follow our LinkedIn page for more insights from the world of clinical trials. Maya Zlatanova, CEO of TrialHub Moe Alsumidaie, Chief Editor of The Clinical Trial Vanguard Must-reads from The Clinical Trial Vanguard Your Guide to Validate Clinical Trial DHTs Stanford’s New Leap in Personalized Medicine and Trials Digital Twins: The Future of Clinical Trials
| |||
| 22 May 2024 | How to Adopt a Beginner’s Mindset in Trials with Leen Kawas | 00:43:21 | |
In this episode, Maya meets Dr. Leen Kawas. Dr. Kawas is creating a biotech-focused fund to support life science innovations, utilizing her background as an inventor, scientist, and entrepreneur. She first led and co-founded Athira, a company for late-stage clinical programs. She took it public in 2020, raising over $400 million. Notably, she was the first woman in 20 years in Washington State, and one of only 22 female founders in the US, to take a company public. Maya and Leen discuss the critical role of patient-centric clinical trial design and the importance of engaging with patients early in the clinical development process to ensure the success of clinical trials. Leen also talks about the challenges and solutions in making clinical trials more effective, including addressing patient diversity, optimizing the patient experience, and the importance of integrating clinical operation insights into clinical research for better outcomes. See a breakdown of all the ideas Maya and Leen share:
(01:09) How Leen Kawas got from a Pharmacist to a Biotech Entrepreneur (02:39) Why a patient-centric approach is crucial for clinical trials (05:36) Lessons from patient interactions (19:23) Why site selection and staff retention are essential (26:33) How to Empower Study Coordinators (28:17) The way to build strong relationships with sites (30:21) How to navigate the challenges with CROs (37:19) How investors evaluate Biotech companies (40:03) What is the future of clinical trials
Maya Zlatanova, CEO of Trialhub Leen Kawas, Co-Founder of Propel Bio Partners See all episodes starring Leen
| |||
| 22 Aug 2024 | Small Patients, Big Challenges: Obstacles in Paediatric Rare Disease Research with Begonya Nafria | 00:34:40 | |
Meet Begonya Nafria - Head of the Patient Engagement in Research Department at Hospital Sant Juan de Déu Children’s Hospital, championing the cause of paediatric clinical research. In this eye-opening episode, Begonya and Maya delve into the unique challenges of conducting clinical trials for children, especially those with rare diseases. Begonya highlights the startling fact that 95% of rare diseases have no approved treatment, emphasizing the urgent need for increased research investment and improved access to cross-border clinical trials for children and young patients in Europe . This conversation underscores the importance of meaningful patient engagement in designing better trials and ultimately improving care outcomes for children and young people.
Follow Begonya Nafria: https://www.linkedin.com/in/bnafria/ Let’s help Begonya's project on language discrimination in cross-border trials: If you’re a parent of a child with a rare disease, please collaborate by responding to this survey (available in 22 European languages): https://bit.ly/Survey_Parents_CT If you’re interested in getting involved as an AMBASSADOR for Begonya’s research project on language discrimination in access to paediatric cross-border clinical trials in Europe, please complete this form: https://bit.ly/CT_Ambassadors | |||
| 18 Oct 2023 | Pioneering Site-Centric Transformation with Raymond Nomizu | 00:26:10 | |
In this episode, Maya and Raymond discuss the following topics: (2:09) What’s happening right now with clinical sites (5:23) Should sites choose their own tech stack (8:24) How to build better ePRO workflows (13:06) The 1 way to offer global solutions for sites (16:09) What is the future of sites (23:09) How can clinical trials get more collaborative Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Raymond Nomizu, Co-Founder of CRIO See More: | |||
| 13 Aug 2024 | The Importance of Patient Engagement on the Outcomes of Clinical Trials with Dr. Lorna Pender | 00:17:20 | |
Meet Dr. Lorna Pender - a passionate patient advocate and engagement expert dedicated to amplifying patient voices in healthcare. In this episode, Lorna and Maya explore the vital role of patient engagement in shaping the clinical trial landscape. Lorna highlights how early patient engagement can drive the success of clinical trials and stresses the importance of industry creating accessible, tailored programs that optimize the patient journey. Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/
| |||
| 19 Nov 2024 | RWD Data and Trust in Clinical Trials: Ritesh Patel’s Take | 00:30:23 | |
Join Maya Zlatanova and Ritesh Patel from Finn Partners as they dive into the evolving world of real-world data in clinical trials. Discover the challenges of integrating diverse patient data, the role of social determinants in trial outcomes, and how emerging technologies like AI and digital biomarkers are set to revolutionize the industry. Packed with insights on collaboration and innovation, this episode is a must-listen for anyone passionate about transforming healthcare through data-driven strategies.
| |||
| 08 Aug 2024 | How Germany’s Standard of Care Influences Clinical Trial Participation with Martin Krauss | 00:36:53 | |
Meet Martin Krauss - the CEO of FGK Clinical Research, an expert in clinical research with a mission to advance medical treatments and improve patient outcomes. One year after their last episode together, Martin and Maya meet again to talk about the current challenges and developments in the clinical research landscape. Why is there a decline in biotechnology investments globally and how is that affecting the dynamics of the market? What are the challenges in implementing the Clinical Trial Information System (CTIS) in Europe? How is the new Medical Research Act in Germany going to increase efficiency and benefit patients?
Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/ Learn more about FGK Clinical Research: https://fgk-cro.com/ | |||
| 22 Sep 2023 | How to Speed Up Clinical Trials with Kimberly Tableman | 00:32:37 | |
In this episode, Maya and Kimberly, Founder and CEO of ESPERO, discuss the following topics: (2:20) What does a Head of Digital Clinical Trials do? (4:36) How can we speed up clinical trials? (7:54) Top inefficient trial processes requiring a shift (12:00) The main challenge in clinical trials (15:38) Bridging the gap between companies and patients (20:00) How to improve protocol design (23:51) Why the industry is still not ready for AI and ML Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Kimberly Tableman, CEO of ESPERO
| |||
| 26 Nov 2024 | Endometriosis: Why Standard Care Isn't Cutting It - Exploring the Gaps with Estelle Jobson | 00:39:33 | |
"Only 1-4% of global healthcare R&D funding is dedicated to female-specific conditions beyond cancer, despite women representing 51% of the population.” Meet Estelle Jobson - an EUPATI Fellow and a patient advocate living with endometriosis. In this episode, Maya and Estelle discuss the limitations of standard care for this chronic condition and call for research that addresses its diverse symptoms.
Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/
| |||
| 17 Apr 2024 | The Big Shift in Cancer Treatment with Gretchen Knoll | 00:35:34 | |
In this episode, Maya meets Gretchen Knoll. She has over 20 years of experience in pharmaceutical clinical development, now she focuses on enhancing care for severely ill patients and reducing healthcare costs through strategic collaborations. Maya and Gretchen Knoll discuss the challenges and potential transformations in clinical research. They delve into the need for a shift from organ-based cancer treatment to tumor classification, the importance of patient empowerment and education, and the potential of AI and predictive analytics in advancing drug discovery and personalized medicine. (00:54) Getting to know Gret Knoll (02:49) Why do we need to shift from organ to receptor-based classification (07:29) The challenges with using molecular testing at scale (15:09) What are the challenges and opportunities in clinical trials (21:20) What is the new role of psychedelics in clinical research (30:17) The power of predictive analytics and AI in medicine (32:40) How to empower patients for better trial outcomes
Maya Zlatanova, CEO of TrialHub Gretchen Knoll, Président and CEO of Wyvern Quill Consulting Follow the show on LinkedIn to connect with guests and learn first about new episodes.
| |||
| 18 Mar 2025 | The Power of Innovative Trial Designs with Philip Raeth | 00:31:47 | |
Clinical trials are evolving, but are we innovating fast enough? In this episode Maya sits down with Philip Raeth from Palleos Healthcare to explore how new trial designs can challenge the status quo. From adaptive methodologies to efficiency-driven models, we discuss how rethinking trial structure can help us tackle industry-wide hurdles—not just in patient recruitment and retention, but in trial execution, costs, and outcomes. What does the future of clinical trials look like? Tune in as we brainstorm new possibilities. Follow Philip Raeth: https://www.linkedin.com/in/philip-raeth-51911114/ | |||
| 05 Sep 2024 | From Carer to Catalyst: Joy Milne's Journey to Revolutionize Parkinson's Research | 00:30:35 | |
| |||
| 06 Sep 2023 | Getting Transparent on Clinical Translations with Duncan Shaw | 00:25:58 | |
In this episode, Maya and Duncan, president of DTS Language Services, shed light on translations involved in clinical trials. They discuss the following topics: (2:09) The mission and purpose behind informed consent (4:35) How to apply D&I to the informed consent (6:45) What problems arise in translating consent forms (10:37) AI and translations in clinical trials (12:47) Best practices in clinical research and translations (15:54) Duncan’s experience from working with sponsors (21:21) What makes or breaks a clinical trial Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Duncan Shaw, President at DTS Language Services See More: | |||
| 05 Jul 2023 | How To Use AI To Accelerate Clinical Trials with Jennifer Bittinger | 00:29:15 | |
In this episode, Maya and Jennifer discuss the benefits of AI in clinical research and how it can assist medical writers in their day-to-day tasks. They also dive deeper into the cons of AI and the importance of the human-in-the-loop approach. They thoroughly discuss the following topics: (4:01) What does Narrativa do? (6:21) How do people feel about AI entering clinical research? (9:23) Are people embracing the technology or is there technology fatigue? (13:25) What are the main challenges for AI? (19:32) Are people’s old habits a barrier to AI entering the life science industry? (21:58) Are companies ready to start working with AI? (25:56) Is AI affordable for small to medium-sized companies? Tune in today and start expanding your knowledge! Maya Zlatanova, CEO of Trialhub Jennifer Bittinger, President at Narrativa See More: | |||
| 21 Feb 2023 | Recruitment Rates in Clinical Trials with Dana Niedzielska | 00:27:14 | |
Maya Zlatanova speaks with the CEO of August Research, Dana Niedzielska. August Research is a clinical research organization based in Europe that provides regulatory, monitoring and project management services for clinical trials. Maya and Dana examine the challenges in patient recruitment and the reliability of recruitment rates. They dive deeper into the planning of clinical trials and the importance of site selection. They also talk about the disparities between the expectations of the clinical investigators and the reality of conducting clinical trials. Here are the key topics that they discuss: (2:33) How much can we trust recruitment rates when we plan clinical trials? (6:53) Disparities between planning and the execution of clinical trials (8:12) When should you seriously consider recruitment rates? (11:31) Risk Management application in clinical trials (13:40) Challenges in site level recruitment (18:11) The challenge of misleading recruitment rates Tune in to learn more! Maya Zlatanova, CEO of Trialhub Dana Niedzielska, CEO of August Research See More: | |||
| 10 Dec 2024 | Patient Engagement and Standard of Care in Rare Disease Trials with Orit Rindner | 00:18:57 | |
In this episode of Trials with Maya Z, Maya and patient expert and advocate Orit Rindner discuss the intersection of patient needs and clinical trials, highlighting real-world challenges and insights from rare disease research:
Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/
| |||
| 17 Sep 2024 | How Access to Treatments Impacts Trials: From Protocol Development, to Country and Site Selection with Kasia Harris | 00:32:45 | |
Follow Kasia Harris: https://www.linkedin.com/in/kasia-harris-md-16316b44/
| |||
| 19 Jun 2024 | How to Ensure Data Integrity and Security in Clinical Research with Daniel Schwarz | 00:22:19 | |
In this episode, Maya meets Daniel Schwarz, a co-founder and CIO at the Institute of Biostatistics and Analyses Ltd., a spin-off from Masaryk University, Brno, Czech Republic. With a robust background in biomedical engineering, neuroimaging, and clinical data management, Daniel's work focuses on leveraging advanced data management systems to support significant healthcare projects. Maya and discuss the following topics: (1:04) Get to know Daniel Schwarz (4:34) What’s the secret sauce to a modern EDC (6:58) Why companies shouldn’t underestimate data management (8:58) What are the regulatory expectations in data management (11:04) The main challenge in starting an EDC from scratch (17:33) The role of AI in EDC and data management (19:40) What can make trials more patient-friendly Follow our LinkedIn page for more insights from the world of clinical trials. Maya Zlatanova, CEO of TrialHub Daniel Schwarz, Co-Founder and CIO at the Institute of Biostatistics and Analyses Ltd.
| |||